Multifocal ground-glass opacities: multifocal origin versus intrapulmonary metastasis
Editorial

Multifocal ground-glass opacities: multifocal origin versus intrapulmonary metastasis

Choon-Taek Lee

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seoul, Korea

Correspondence to: Choon-Taek Lee. Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seoul, Korea. Email: ctlee@snu.ac.kr.

Provenance: This is an invited Editorial commissioned by the Section Editor Jun Zhou (Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China).

Comment on: Li R, Li X, Xue R, et al. Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs). Thorax 2018;73:290-2.


Submitted Jan 26, 2018. Accepted for publication Feb 13, 2018.

doi: 10.21037/jtd.2018.03.25


Multifocal origin or intrapulmonary metastasis; that is the question (1).

Introduction of low-dose computed tomography (LDCT) of the chest for lung cancer screening has facilitated the detection of many lung nodules, including ground-glass opacity nodules (GGNs). Most GGNs have only been detected using LDCT. More than one GGN were found in a patient. There are no existing correct data; however, more than 10% of patients with GGNs harbor more than one GGN.

Whenever we encounter patients with multiple GGNs, it is not easy to determine whether multiple GGNs indicate intrapulmonary metastasis or multifocal origin. For example, the stage of lung cancer would differ if a patient harbors a GGN with solid portion of 1.5 cm in the right upper lobe and another GGN of 0.8 cm solid portion in the left upper lobe. If the two GGNs occurred independently, the T stages would be T1b and T1a, respectively, and overall stages would be IA2 and IA1, respectively. However, they would be staged as M1a and IVA if the two GGNs were intrapulmonary metastases.

Two major mechanisms have been proposed by which histologically similar multifocal tumors arise: (I) a single clonal event resulting in a tumor that subsequently spreads within one or both lungs (aerogenous intrapulmonary metastasis) and (II) multiple tumors arising independently in a carcinogen-damaged field (field cancerization, multiclonality) (2).

Traditionally, the determination of multiple tumors or metastases was followed by the Martini and Melamed criteria (3). They defined multiple tumors as either (I) tumors showed different pathologies, or (II) those that showed the same pathologies when the following criteria were met: the origin was from a carcinoma in situ, with no lymph node involvement in the common lymphatic pathways, and no extra-thoracic metastasis.

According to Martini and Melamed’s criteria, multiple GGNs would be multifocal in origin. However, whether these criteria are still valid in cases of multiple GGNs remains unclear.

Most GGNs are atypical adenomatous hyperplasia, adenocarcinoma in situ, or pathological adenocarcinoma, and arise from the alveolar membrane with no lymph node involvement and no extra-thoracic metastasis. This issue has been investigated extensively with modern technology, such as genetic analysis. Most GGNs are basically adenocarcinomas, even though there are minor differences in subtype, and numerous genetic alterations have been proven to be involved in the carcinogenesis of adenocarcinoma. Therefore, the status of genetic alterations of GGNs could be a marker of clonality (4).

My group has already investigated alterations in epidermal growth factor receptor (EGFR) and K-ras in multiple GGNs among 24 patients, and found that a high frequency of discordant EGFR mutations (17 of 24, 70.8%) could discriminate different tumor clonalities (18 of 24, 75%) of multiple lung neoplastic nodules presenting as GGNs (5). Many reports have supported the theory of multiple clonalities of multiple GGNs and are summarized in Table 1.

Table 1
Table 1 Summary of selected papers on clonality of multifocal GGNs or lung nodules
Full table

Therefore, the theory of different clonalities of multiple GGNs in patients was generally accepted.

Recent modifications of T staging of multiple GGNs in the 8th tumor-node-metastasis (TNM) classification of the International Association for the Study of Lung Cancer (IASLC) were also based on multiclonality rather than intrapulmonary metastasis. It proposed that T staging of multifocal GGNs was determined by high T lesions, with either the number of tumors or m in parentheses to denote the multifocal nature (12). According to multifocal origin, surgery for dominant GGNs by lobectomy or, more preferably, limited resection is recommended and then close follow-up of remaining GGNs is warranted (13).

However, there may be a possibility of intrapulmonary metastasis of small multifocal GGNs.

When we examined the pathological specimens of resected GGNs, small tumor nests in alveolar sacs or in bronchial lumen were frequently observed. This finding strongly suggests the potential of intrabronchial spread of GGNs. Kadota et al. (14) reported that tumors spread through air space (STAS), which were defined as tumor cells—micropapillary structures, solid nests, or single cells—spreading within air spaces in the lung parenchyma beyond the edge of the main tumor, was a significant risk factor of recurrence in small lung adenocarcinomas treated with limited resection. This finding could be clinical evidence of early metastasis of small GGNs.

Recent introduction of next-generation sequencing (NGS) enables us to complete analysis of tumor clonality easily by measuring whole-genome, exome, or target gene sequences (8,10).

Li et al. (11) analyzed the clonalities of multiple GGNs with matched blood samples in two patients using exome sequencing and found that two GGNs in each patient shared multiple nonsynonymous and synonymous mutations, which strongly suggested intrapulmonary metastasis, and remaining GGNs showed different clonalities. This finding has great impact on the management of multiple GGNs. I believe that the strategy of resection of dominant GGNs and close follow-up of remaining nodules would be optimal; however, complete analysis of genetic mutations using NGS would be necessary for the management of patients in the future. From these reports, it is reasonable to conclude that multiple GGNs are multifocal in origin, however, small portion of GGN might be the result of intrapulmonary metastasis.

The cause of GGNs may be a major issue that remains unresolved. Smoking—a major cause of lung cancer—may not be a causative factor in GGNs as most patients are non-smokers. There are several differences between lung cancer with GGNs and typical lung cancer. GGN is not associated with smoking, unlike smoking-related lung cancer. GGNs occur at a relatively young age and show a very indolent course. Moreover, they develop in the peripheral portion of the lungs and many of them have a multifocal origin (15). A previous study suggested that genetic susceptibility, household air pollution attributed to solid fuel burning for heating and cooking, and cooking fumes as causative agents in China (16); however, there is no clear evidence to support this hypothesis.

Field cancerization theory could be applied to GGNs because of their multiplicity in air space. Personally, I think inhaled environmental carcinogens could be a cause of GGN-type lung cancer and am eagerly awaiting the next research that elucidates the issue. Understanding the etiology of GGNs is very important for the prevention of GGNs and development of novel management strategies.


Acknowledgements

None


Footnote

Conflicts of Interest: The author has no conflicts of interest to declare.


References

  1. Asamura H. Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol 2010;5:930-1. [Crossref] [PubMed]
  2. Gazdar AF, Minna JD. Multifocal lung cancers--clonality vs field cancerization and does it matter? J Natl Cancer Inst 2009;101:541-3. [Crossref] [PubMed]
  3. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606-12. [PubMed]
  4. Schneider F, Dacic S. Histopathologic and molecular approach to staging of multiple lung nodules. Transl Lung Cancer Res 2017;6:540-9. [Crossref] [PubMed]
  5. Chung JH, Choe G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol 2009;4:1490-5. [Crossref] [PubMed]
  6. Takamochi K, Oh S, Matsuoka J, et al. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras. Lung Cancer 2012;75:313-20. [Crossref] [PubMed]
  7. Wu C, Zhao C, Yang Y, et al. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules. J Thorac Oncol 2015;10:778-83. [Crossref] [PubMed]
  8. Liu Y, Zhang J, Li L, et al. Genomic heterogeneity of multiple synchronous lung cancer. Nat Commun 2016;7:13200. [Crossref] [PubMed]
  9. Liu M, He WX, Song N, et al. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities. Eur J Cardiothorac Surg 2016;50:909-13. [Crossref] [PubMed]
  10. Saab J, Zia H, Mathew S, et al. Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis. Transl Oncol 2017;10:442-9. [Crossref] [PubMed]
  11. Li R, Li X, Xue R, et al. Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs). Thorax 2018;73:290-2. [Crossref] [PubMed]
  12. Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol 2016;11:666-80.
  13. Kim HK, Choi YS, Kim J, et al. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010;5:206-10. [Crossref] [PubMed]
  14. Kadota K, Nitadori J, Sima CS, et al. Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas. J Thorac Oncol 2015;10:806-14. [Crossref] [PubMed]
  15. Lee CT. What do we know about ground-glass opacity nodules in the lung? Transl Lung Cancer Res 2015;4:656-9. [PubMed]
  16. Hosgood HD 3rd, Song M, Hsiung CA, et al. Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA). Hum Genet 2015;134:333-41. [Crossref] [PubMed]
Cite this article as: Lee CT. Multifocal ground-glass opacities: multifocal origin versus intrapulmonary metastasis. J Thorac Dis 2018;10(3):1253-1255. doi: 10.21037/jtd.2018.03.25